{"lastClose": 20.25, "len": 552, "date": "2023-02-22", "alpha_1": 0.8446224818337729, "beta_1": 1.270062276923129, "drawup_1": 3.4823943404800426, "sharpe_1": 0.8392106078157169, "natr_1": 6.549472443526834, "sup_1": -0.12197530613024055, "res_1": 0.43111111990218287, "bullPattern_1": ["ENGULFING"], "bearPattern_1": [], "rsi_1": 43.425759832248886, "adx_1": 9.38228075111763, "drawdown_1": -0.6561743540588539, "stratHoldSharpe_1": 0.81169801743616, "stratHoldAlpha_1": 251.67681207638586, "stratHoldDrawdown_1": -0.6001476570104074, "alpha_3mo": -0.49223086301020347, "beta_3mo": 1.1201405981682078, "drawup_3mo": 0.18998442118667414, "natr_3mo": 6.549472443526834, "sup_3mo": -0.08082301135906945, "res_3mo": 0.047489715701758674, "bullPattern_3mo": ["SPINNINGTOP"], "bearPattern_3mo": [], "rsi_3mo": 43.66632513795376, "adx_3mo": 22.68158352289182, "drawdown_3mo": -0.27454831195894147, "stratHoldSharpe_3mo": -0.34446274682973294, "stratHoldAlpha_3mo": 250.7637931748426, "stratHoldDrawdown_3mo": -0.24962304660894363, "Industry": "Biotechnology: Pharmaceutical Preparations", "Country": "United States", "Market Cap": 652706417, "Name": "4D Molecular Therapeutics Inc.", "Sector": "Health Care", "IPO Year": 2020.0, "alpha%_1": 0.9985172172134608, "beta%_1": 0.7134215963764297, "drawup%_1": 0.9999999999999999, "sharpe%_1": 0.5747744717900853, "natr%_1": 0.8587966990982993, "drawdown%_1": 0.0781977220451207, "stratHoldSharpe%_1": 0.8197889857027825, "stratHoldAlpha%_1": 0.9918164521163254, "stratHoldDrawdown%_1": 0.07922838632123469, "alpha%_3mo": 0.1194007462641758, "beta%_3mo": 0.5996789326405015, "drawup%_3mo": 0.3570356250248833, "natr%_3mo": 0.8498312703409847, "drawdown%_3mo": 0.06123001592433824, "stratHoldSharpe%_3mo": 0.2813035904042356, "stratHoldAlpha%_3mo": 0.21778393726748646, "stratHoldDrawdown%_3mo": 0.060854477662981216}